Medical Packaging Company manufactures and sells glass packaging for pharmaceutical and medical purposes in Egypt and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||ج.م0.41|
|52 Week High||ج.م0.33|
|52 Week Low||ج.م1.14|
|1 Month Change||-20.31%|
|3 Month Change||-20.93%|
|1 Year Change||9.68%|
|3 Year Change||153.42%|
|5 Year Change||187.32%|
|Change since IPO||-65.48%|
Recent News & Updates
|MEPA||EG Packaging||EG Market|
Return vs Industry: MEPA underperformed the EG Packaging industry which returned 101.7% over the past year.
Return vs Market: MEPA underperformed the EG Market which returned 11.1% over the past year.
Stable Share Price: MEPA is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: MEPA's weekly volatility (7%) has been stable over the past year.
About the Company
Medical Packaging Company manufactures and sells glass packaging for pharmaceutical and medical purposes in Egypt and internationally. The company offers ampoule form A, B, C, and D; ampoule marzocchi; vial; and aluminum caps. It also provides one-point cut ampoules, ceramic printed ampoules, and other products in various designs, sizes, and colors, as well as various flat based and constricted neck ampoules, and flame cut ampoules for the packaging of pharmaceutical liquid products.
Medical Packaging Fundamentals Summary
|MEPA fundamental statistics|
Is MEPA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MEPA income statement (TTM)|
|Cost of Revenue||ج.م29.32m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.017|
|Net Profit Margin||14.87%|
How did MEPA perform over the long term?See historical performance and comparison
Is Medical Packaging undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: MEPA (EGP0.41) is trading above our estimate of fair value (EGP0.4)
Significantly Below Fair Value: MEPA is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MEPA is poor value based on its PE Ratio (23.5x) compared to the African Packaging industry average (9.8x).
PE vs Market: MEPA is poor value based on its PE Ratio (23.5x) compared to the EG market (11.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MEPA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MEPA is overvalued based on its PB Ratio (2x) compared to the XF Packaging industry average (1.3x).
How is Medical Packaging forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Materials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medical Packaging has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Medical Packaging performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MEPA has high quality earnings.
Growing Profit Margin: MEPA's current net profit margins (14.9%) are lower than last year (16.8%).
Past Earnings Growth Analysis
Earnings Trend: MEPA has become profitable over the past 5 years, growing earnings by 57.9% per year.
Accelerating Growth: MEPA's earnings growth over the past year (2.4%) is below its 5-year average (57.9% per year).
Earnings vs Industry: MEPA earnings growth over the past year (2.4%) underperformed the Packaging industry 6.7%.
Return on Equity
High ROE: MEPA's Return on Equity (8.6%) is considered low.
How is Medical Packaging's financial position?
Financial Position Analysis
Short Term Liabilities: MEPA's short term assets (EGP31.5M) do not cover its short term liabilities (EGP35.5M).
Long Term Liabilities: MEPA's short term assets (EGP31.5M) exceed its long term liabilities (EGP4.5M).
Debt to Equity History and Analysis
Debt Level: MEPA's debt to equity ratio (31.3%) is considered satisfactory.
Reducing Debt: MEPA's debt to equity ratio has reduced from 50.8% to 31.3% over the past 5 years.
Debt Coverage: MEPA's debt is not well covered by operating cash flow (15.4%).
Interest Coverage: Insufficient data to determine if MEPA's interest payments on its debt are well covered by EBIT.
What is Medical Packaging current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MEPA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MEPA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MEPA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MEPA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MEPA's dividend in 3 years as they are not forecast to pay a notable one for the EG market.
How experienced are the management team and are they aligned to shareholders interests?
Dr. Mahir Moosa Syed serves as Managing Director of Medical Packaging Company.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Medical Packaging Company's employee growth, exchange listings and data sources
- Name: Medical Packaging Company
- Ticker: MEPA
- Exchange: CASE
- Founded: 2006
- Industry: Metal and Glass Containers
- Sector: Materials
- Market Cap: ج.م140.760m
- Shares outstanding: 345.00m
- Website: https://www.med-pack.com
- Medical Packaging Company
- 124 Osman Abn Afan
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/22 14:31|
|End of Day Share Price||2021/10/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.